TrialBMJ (Clinical research ed.)2025

Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial.

Yuejun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.